Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-000059
Accepted
2020-01-10 00:15:26
Documents
1
Effectiveness Date
2020-01-09
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 602
  Complete submission text file 9999999995-20-000059.txt   1830
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-235762 | Film No.: 20519354
SIC: 2835 In Vitro & In Vivo Diagnostic Substances